Experimental study of biomass waste gasification: Impact of atmosphere and catalysts presence on quality of syngas production.

The presented research results the gasification process of biomass waste (brewery spend grain, wheat straw, hay, pine sawdust). Experimental investigations focused on determining the influence of gasification agent (CO2, steam, and steam and CO2 mixture) and the presence of a solid catalyst (MgO∙CaO, TiO2, CuO and SrO). Investigations were performed towards syngas production. A wide range of analyses and instrumental methods were used to determine the properties of gasification process products, including: GC, TGA, FTIR, SEM, BET. The main component of syngas obtained produced in atmosphere CO2 and steam mixture was hydrogen. The H2 concentration increased from 20% up to 44% in case of brewery spend grain. The presence of the catalyst in the gasification process favoured the tar cracking reaction. The amount of tar was reduced by more than 17% in case of brewery spend grain. As well as syngas composition was enriched with CH4, H2 and CO concentration.

Phenolic fractions from nine Trifolium species modulate the coagulant properties of blood plasma in vitro without cytotoxicity towards blood cells.

OBJECTIVE: The study covers an evaluation of the influence of extracts (1-50 µg/ml), isolated from aerial parts of nine Trifolium L. species (i.e. T. alexandrinum, T. fragiferum, T. hybridum, T. incarnatum, T. pallidum, T. pratense, T. resupinatum var. majus, T. resupinatum var. resupinatum and T. scabrum) on haemostatic properties of blood plasma. METHODS: The clot formation and fibrinolysis assay (CFF), blood clotting times, the extrinsic and intrinsic coagulation pathway-dependent polymerization of plasma fibrin were measured. The effects of plant extracts on amidolytic activity of thrombin were also evaluated and compared with argatroban, an antithrombotic drug. Cytotoxicity was assessed in a model of blood platelets and as the viability of peripheral blood mononuclear cells. KEY FINDINGS: While no changes in blood clotting times or fibrinolytic properties of blood plasma were found, some fractions impaired the blood plasma coagulation induced by the intrinsic coagulation pathway. Reduction in the maximal velocity of fibrin polymerization was also observed in the clot formation and fibrinolysis assay. No cytotoxicity of Trifolium extracts towards the investigated cells was recorded. CONCLUSIONS: The most efficient anticoagulant activity in plasma was found for T. fragiferum and T. incarnatum extracts, while the T. alexandrinum fraction was the most effective inhibitor of thrombin amidolytic activity.

Clovamide and clovamide-rich extracts of three Trifolium species as antioxidants and moderate antiplatelet agents in vitro.

This in vitro study provides a new insight into the phytochemical, antioxidant, antiplatelet and cytotoxic profiles of commercial trans-clovamide and clovamide-rich extracts, isolated from aerial parts of three Trifolium species (i.e. T. clypeatum L., T. obscurum Savi and T. squarrosum L.). Under inorganic experimental conditions, the EC50 for the investigated substances varied between 4.87 (clovamide) and 7.91 µg/ml (T. clypeatum) according to the DPPH• assay. The most effective 1 mM ONOO- scavenger was clovamide (IC50 = 19.29 µg/ml), and the weakest was the T. obsucurum extract (IC50 = 41.79 µg/ml). The antioxidant action of the examined substances (1-50 µg/ml) was also evaluated in blood plasma (under 100 µM ONOO--induced oxidative stress) using 3-nitrotyrosine, protein thiol groups, lipid hydroperoxides and thiobarbituric acid-reactive substances as biomarkers. All examined substances were more effective in limiting the oxidative damage to blood plasma components than the nitrative damage. Their anti-nitrative action was statistically significant only at the highest concentration (50 µg/ml). Measurements of platelet adhesion and aggregation found the compounds to have moderate antiplatelet properties of up to 20% inhibition of platelet adhesion at concentrations of 1-5 µg/ml. Additionally, clovamide and Trifolium extracts demonstrated no cytotoxicity towards blood platelets or peripheral blood mononuclear cells.

Bufadienolides from Kalanchoe daigremontiana as thrombin inhibitors-In vitro and in silico study.

Thrombin is an active plasma coagulation factor II, critical for the formation of fibrin clot during blood coagulation. For that reason, this protein is also a crucial target for different anti-thrombotic therapies. The work is based on in vitro evaluation of the inhibitory effect of bufadienolide-rich fraction, isolated from roots of Kalanchoe daigremontiana (1-50µg/ml) on enzymatic properties of a serine proteinase - thrombin. The efficacy of the inhibition of amidolytic activity of thrombin (measured as a hydrolysis of the chromogenic substrate S-2238, Chromogenix) attained about 10 and 66%, respectively. The IC50, established for the examined bufadienolide fraction was 2.79µg/ml, while the IC50 calculated for argatroban (reference compound) was 0.78µg/ml. Linearization conducted using Lineweaver-Burk plot indicated that the K. daigremontiana fraction contains compounds that are uncompetitive inhibitors of thrombin. K. daigremontiana fraction was also able to reduce the proteolytic activity of thrombin towards its physiological substrate, i.e. fibrinogen. Additionally, this study is supported by in silico analysis of interactions of the most common compounds, identified in the examined in Kalanchoe extract to crystal structure of this enzyme.

The anti-adhesive and anti-aggregatory effects of phenolics from Trifolium species in vitro.

The present in vitro study includes a comparative evaluation of anti-platelet (anti-thrombotic) properties of plant phenolics, isolated from nine different clover (Trifolium) species. The analysis covered phenolic fractions isolated from T. alexandrinum L., T. fragiferum L., T. hybridum L., T. incarnatum L., T. pallidum Waldst et Kit., T. resupinatum L. var. majus Boiss, T. resupinatum L. var. resupinatum, T. scabrum L., and T. pratense L. (red clover). The inhibitory effects of plant preparations (1-50 µg/ml) on hemostatic functions of blood platelets were assessed by measurements of thrombin- or ADP-induced platelet adhesion to fibrinogen, platelet aggregation in platelet-rich plasma (activated with ADP or collagen), and by the determination of PF-4 secretion from platelet α-granules. The influence of T. phenolics on arachidonic cascade in blood platelets was also determined. T. resupinatum var. majus, T. resupinatum var. resupinatum, and T. scabrum had the strongest anti-platelet effects. These preparations displayed the most evident anti-adhesive and anti-aggregatory effects in response to all of the used agonists: thrombin (0.2 U/ml), ADP (10 µM), and collagen (2 µg/ml), and their inhibitory properties were also confirmed by an analysis of PF-4 secretion. T. scabrum and some of other examined clover species possess significantly higher concentrations of both isoflavones and other bioactive phenolics, when compared to red clover. The obtained results suggest that these clovers contain substances with potent anti-platelet properties.